Effects of NEPA (novel combination of netupitant and palonosetron) on ECG of healthy volunteers: A randomized, controlled, thorough ECG trial.

Trial Profile

Effects of NEPA (novel combination of netupitant and palonosetron) on ECG of healthy volunteers: A randomized, controlled, thorough ECG trial.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2013

At a glance

  • Drugs Netupitant/palonosetron (Primary) ; Moxifloxacin
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jun 2013 New trial record
    • 31 May 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top